Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery

NCT02113150 is registered in ClinicalTrials.gov with Turkiye Yuksek Ihtisas Education and Research Hospital as lead sponsor.

NCT NCT02113150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02113150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery
Lead sponsor
Turkiye Yuksek Ihtisas Education and Research Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2013
Completion date
September 30, 2013
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease